International Journal of Innovative Technologies in Social Science https://rsglobal.pl/index.php/ijitss <p style="line-height: 1.5;"><strong>e-ISSN:</strong> 2544-9435<br><strong>DOI:</strong> 10.31435/rsglobal_ijitss<br><strong>OCLC Number:</strong> 1036501433<br><strong>Publisher:</strong> RS Global Sp. z O.O., Poland<br><strong>Operated by:</strong> <a href="https://sciformat.ca/" target="_blank" rel="noopener">SciFormat Publishing Inc.</a>, Canada<br><strong>Subject area:</strong> Social Sciences<br><strong>Submission to publication:</strong> 59 days<br><strong><span class="sc-hwwEjo cdchLr">Acceptance rate: </span></strong><span class="sc-kPVwWT hZDpyF">55%</span></p> en-US <p>All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.<br>CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.</p> editorial_office@rsglobal.pl (RS Global - IJITSS) support@rsglobal.pl (Technical Support) Tue, 30 Dec 2025 00:00:00 +0000 OJS 3.1.2.1 http://blogs.law.harvard.edu/tech/rss 60 THE BACTERICIDAL PROTEINS OF THE EPIDERMIS https://rsglobal.pl/index.php/ijitss/article/view/4105 <p><span lang="EN-GB">The skin is the biggest human’s organ. It is concerned with plenty of functions, such as: providing protection against harmful factors of the external environment, both chemical and physical, or regulating temperature and the amount of evaporating water. It is responsible for receiving sensory stimuli and vitamin D3 synthesis. However, this review focuses on an underestimated role of the skin as a barrier against bacteria, maintained thanks to the human’s natural antibiotics – the antimicrobial proteins of the epidermis.</span></p> Marcel Bobiński, Aleksandra Bubnowska, Wiktoria Skowron, Kamil Kania, Rozalia Kujawa, Anna Rogala, Bartosz Frańczak, Konrad Rzymski, Klaudia Romejko, Justyna Bartol Copyright (c) 2025 Marcel Bobiński, Aleksandra Bubnowska, Wiktoria Skowron, Kamil Kania, Rozalia Kujawa, Anna Rogala, Bartosz Frańczak, Konrad Rzymski, Klaudia Romejko, Justyna Bartol https://creativecommons.org/licenses/by/4.0 https://rsglobal.pl/index.php/ijitss/article/view/4105 Thu, 30 Oct 2025 00:00:00 +0000 LONG-TERM EFFECTS OF DENTAL IMPLANTS IN PATIENTS WITH OSTEOPOROSIS - A LITERATURE REVIEW https://rsglobal.pl/index.php/ijitss/article/view/4081 <p><strong>Introduction:</strong> Osteoporosis, a common metabolic bone disease affecting over 200 million people globally, causes decreased bone mass and structural deterioration, increasing fracture risk and reducing quality of life. Dental implants have become a standard treatment for tooth loss, providing functional and aesthetic restoration. However, in osteoporotic patients, compromised bone quality may challenge osseointegration and long-term implant stability, requiring careful assessment and individualized planning.</p> <p><strong>Methodology:</strong> A literature review of PubMed, Scopus, and Google Scholar identified recent systematic reviews and meta-analyses on dental implant outcomes in osteoporotic patients, focusing on implant survival, bone loss, and antiresorptive therapy, with studies ≥1-year follow-up included.</p> <p><strong>Results:</strong> Most studies show no significant difference in implant survival between osteoporotic and healthy patients, with rates typically above 90%. Slight but significant marginal bone loss was noted, though clinically minor. Bone density and osseointegration were generally comparable, particularly with individualized care and antiresorptive therapy. Osteonecrosis of the jaw was rare and mainly associated with bisphosphonate use. Age, systemic treatment, and local bone conditions influenced outcomes. Factors including patient age, systemic therapy, and local bone conditions influenced implant outcomes.</p> <p><strong>Conclusion:</strong> Dental implants in osteoporotic patients demonstrate high survival and predictable outcomes. Minor bone loss is manageable with monitoring and preventive care. Although antiresorptive therapy may increase osteonecrosis risk, interdisciplinary management minimizes complications. Osteoporosis should not be viewed as a contraindication for implant therapy, though further research is needed to refine treatment protocols.</p> Zuzanna Rabczak, Karolina Kasprzak, Małgorzata Kuczek, Aleksandra Wiśniewska, Julia Marek, Mateusz Jasiński, Michał Szalach, Marcin Narloch Copyright (c) 2025 Zuzanna Rabczak, Karolina Kasprzak, Małgorzata Kuczek, Aleksandra Wiśniewska, Julia Marek, Mateusz Jasiński, Michał Szalach, Marcin Narloch https://creativecommons.org/licenses/by/4.0 https://rsglobal.pl/index.php/ijitss/article/view/4081 Thu, 30 Oct 2025 00:00:00 +0000